Can X4 Pharmaceuticals Xfor Stock Reach New Highs Price At 4.12 Up 0.49 20260328 Workday Shares Rally as Growing AI Adoption Alleviates Investor Worries CVRx to Present at Goldman Sachs Healthcare Conference Key Insights for Investors Traders Bet on IonQ Micron Anduril as Next Potential US Government Stake Targets Ferraris Electric Vehicle Ambitions Raise Concerns Over Brand Identity Analysts Suggest Borosil Glass Works Surges Over 200 in a Year Key Drivers Behind the Rally LG Energy Solution Surges After Securing Major US Battery Storage Deal ACIU Q1 2026 Earnings Narrower Net Loss Highlights Cost Discipline in PreRevenue Phase CRESY Q1 2026 Earnings Strong EPS Amid Limited Disclosure Stock Slightly Down PSQH Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue Absence Omnicell Inc OMCL Q1 2026 Earnings EPS Surges Past Estimates Stock Slips Waste Connections Inc Q1 2026 Earnings EPS Beats Estimates Despite Flat Revenue Outlook NNOX Q4 2025 Earnings EPS Misses Estimates Amid Lack of Reported Revenue 51Talk COE Holds Near 263 After Marginal Decline Key Support at 2498 in Focus Larimar Therapeutics LRMR Holds Steady Near Support After Modest Gain Coeptis Therapeutics COEP Consolidates Near 164 Amid Neutral Market Sentiment Babcock Wilcox Senior Notes BWNB Hold Steady Near Par as 2026 Maturity Approaches Nuveen Core Equity Alpha Fund JCE Holds Steady Near Resistance as Volume Patterns Suggest Caution Encompass Health Corporation EHC Q1 2026 Earnings EPS Surpasses Estimates by Nearly 6 Ennis Inc Q1 2026 Earnings EPS Misses Estimates Amid Mixed Operational Conditions INSM Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues OCUL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Development USCB Q1 2026 Earnings EPS Beat on Core Banking Strength RCKT Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Clinical Progress Qualcomm QCOM Gains AI Momentum Ken Fishers Portfolio Highlights Data Center Opportunities ALAR Q4 2025 Earnings A Surprising EPS Beat Drives Positive Market Reaction RDACR Rights Remain Steady at 012 as Speculative Interest Holds NEN Q4 2024 Earnings Strong PerUnit Earnings Highlight Steady Real Estate Performance CEVA Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Beat ATS Q1 2026 Earnings EPS Beats Estimates as Stock Declines 137 Willdan Group Q1 2026 Earnings EPS Beat Drives 32 Stock Gain HOFT Q1 2026 Earnings EPS Misses Estimates Yet Stock Rises on Underlying Strength OppFi Inc Q1 2026 Earnings EPS Surpasses Estimates Amidst Solid Operational Performance HBANM Q1 2026 Earnings Preferred Dividend Coverage Falls Short of Expectations